Skip to content
RDL Network logo
Efficacy of a New Small-Molecule Inhibitor of Histone Deacetylase 6 (HDAC6) in Preclinical Models of B-Cell Lymphoma and Acute Myeloid Leukemia — Montserrat Pérez-Salvia (2018) | RDL Network